Loading…
Reported covered position: DoL Case officer and Confidential Assistant to the Deputy Secretary. Staff Assistant, House Committee on Education and the Workforce
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Educational Choice for Children Act
Client: INVEST IN EDUCATION COALITION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to primary education S. 120 Educational Choice for Children Act H.R.531 Educational Choice for Children Act
Educational Choice for Children Act
Client: INVEST IN EDUCATION COALITION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to primary education S. 120 Educational Choice for Children Act H.R.531 Educational Choice for Children Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · second_quarter · Q2
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to Patent reform Implementation of H.R.5376 Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMFAR THE FOUNDATION FOR AIDS RESEARCH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · second_quarter · Q2
Source: Senate LDA
| TEXAS CHILDREN'S HOSPITAL |
| 4 |
| 2022–2023 |
| INVEST IN EDUCATION COALITION | 3 | 2022–2023 |
| LIFEPOINT HEALTH | 3 | 2022–2023 |
| MONOGRAM HEALTH | 3 | 2022–2023 |
| CHSPSC, LLC | 2 | 2023 |
| LILLY USA, LLC | 1 | 2023 |
Consolidated Appropriations Act, 2023
Client: LIFEPOINT HEALTH · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Rural healthcare coverage and reimbursement Student loan repayment Public Health Emergency policies and funding Competition issues Healthcare workforce and staffing issues H.R. 2617 Consolidated Appropriations Act, 2023
Inflation Reduction Act of 2022
Client: INSPERITY SERVICES, L.P. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Healthcare; Department of Labor regulations; issues related to COVID-19 relief; H.R.5376 Inflation Reduction Act of 2022
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to patent reform Implementation of H.R.5376 Inflation Reduction Act of 2022
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to Patent reform Implementation of H.R.5376 Inflation Reduction Act of 2022
Consolidated Appropriations Act, 2023
Client: LIFEPOINT HEALTH · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Rural healthcare coverage and reimbursement Student loan repayment Public Health Emergency policies and funding Competition issues Healthcare workforce and staffing issues H.R. 2617, Consolidated Appropriations Act, 2023
National Defense Authorization Act for Fiscal Year 2022
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations HR 7309 - Workforce Innovation and Opportunity Act of 2022 S 1260 - United States Innovation and Competition Act of 2021 HR 4521 - America COMPETES Act of 2022 H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022
United States Innovation and Competition Act of 2021
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations H.R. 7309 - Workforce Innovation and Opportunity Act of 2022 S. 1260 - United States Innovation and Competition Act of 2021 H.R. 4521 - America COMPETES Act of 2022
United States Innovation and Competition Act of 2021
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations HR 7309 - Workforce Innovation and Opportunity Act of 2022 S 1260 - United States Innovation and Competition Act of 2021 HR 4521 - America COMPETES Act of 2022 H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022
United States Innovation and Competition Act of 2021
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations H.R. 7309 - Workforce Innovation and Opportunity Act of 2022 S 1260 - United States Innovation and Competition Act of 2021 H.R. 4521 - America COMPETES Act of 2022 H.R. 7776, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Inflation Reduction Act of 2022
Client: INSPERITY SERVICES, L.P. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Healthcare Department of Labor regulations Issues related to COVID-19 relief H.R.5376 - Inflation Reduction Act of 2022
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.5801 - HELP Copays Act H.R.5376 Inflation Reduction Act of 2022
Inflation Reduction Act of 2022
Client: INSPERITY SERVICES, L.P. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Healthcare Department of Labor regulations Issues related to COVID-19 relief H.R.5376 - Build Back Better Act
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.5801 - HELP Copays Act H.R.5376 Inflation Reduction Act of 2022
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.5801 - HELP Copays Act H.R.5376 Inflation Reduction Act of 2022
Inflation Reduction Act of 2022
Client: INSPERITY SERVICES, L.P. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Healthcare Department of Labor regulations Issues related to COVID-19 relief H.R.5376 - Inflation Reduction Act of 2022
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform H.R. 5801 - HELP Copays Act H.R. 5376 - Build Back Better Act
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.5801 - HELP Copays Act H.R.5376 Inflation Reduction Act of 2022
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.5801 - HELP Copays Act H.R.5376 Inflation Reduction Act of 2022
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform H.R. 5801 - HELP Copays Act H.R. 5376 - Build Back Better Act
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.5801 - HELP Copays Act H.R.5376 Inflation Reduction Act of 2022
Workforce Innovation and Opportunity Act of 2022
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations H.R. 7309 - Workforce Innovation and Opportunity Act of 2022 S 1260 - United States Innovation and Competition Act of 2021 H.R. 4521 - America COMPETES Act of 2022 H.R. 7776, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Workforce Innovation and Opportunity Act of 2022
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations H.R. 7309 - Workforce Innovation and Opportunity Act of 2022 S. 1260 - United States Innovation and Competition Act of 2021 H.R. 4521 - America COMPETES Act of 2022
Workforce Innovation and Opportunity Act of 2022
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations HR 7309 - Workforce Innovation and Opportunity Act of 2022 S 1260 - United States Innovation and Competition Act of 2021 HR 4521 - America COMPETES Act of 2022 H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022
James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations H.R. 7309 - Workforce Innovation and Opportunity Act of 2022 S 1260 - United States Innovation and Competition Act of 2021 H.R. 4521 - America COMPETES Act of 2022 H.R. 7776, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Educational Choice for Children Act
Client: INVEST IN EDUCATION COALITION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to primary education S.4416 - Educational Choice for Children Act H.R.8137 Educational Choice for Children Act
Educational Choice for Children Act
Client: INVEST IN EDUCATION COALITION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to primary education S.4416 - Educational Choice for Children Act H.R.8137 Educational Choice for Children Act
United States Innovation and Competition Act of 2021
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations HR 7309 - Workforce Innovation and Opportunity Act of 2022 S 1260 - United States Innovation and Competition Act of 2021 HR 4521 - America COMPETES Act of 2022 H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022
United States Innovation and Competition Act of 2021
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations H.R. 7309 - Workforce Innovation and Opportunity Act of 2022 S 1260 - United States Innovation and Competition Act of 2021 H.R. 4521 - America COMPETES Act of 2022 H.R. 7776, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
United States Innovation and Competition Act of 2021
Client: CHEGG, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to digital learning FY 23 appropriations H.R. 7309 - Workforce Innovation and Opportunity Act of 2022 S. 1260 - United States Innovation and Competition Act of 2021 H.R. 4521 - America COMPETES Act of 2022
Educational Choice for Children Act
Client: INVEST IN EDUCATION COALITION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to primary education S.4416 - Educational Choice for Children Act H.R.8137 Educational Choice for Children Act
Educational Choice for Children Act
Client: INVEST IN EDUCATION COALITION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to primary education S.4416 - Educational Choice for Children Act H.R.8137 Educational Choice for Children Act
Engage in advocacy and appropriations measures in support of amFAR's initiatives supporting HIV/AIDs resrearch PEPFAR Reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
CHSPSC, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · second_quarter · Q2
Issues related to healthcare policy and Covid-19 relief Issues related to telemedicine Rural extenders Issues related to medical debt
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Rural healthcare coverage and reimbursement Student loan repayment Public Health Emergency policies and funding Competition issues Healthcare workforce and staffing issues H.R. 2617 Consolidated Appropriations Act, 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MONOGRAM HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Issues related to in-home kidney care Medicare advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMFAR THE FOUNDATION FOR AIDS RESEARCH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Engage in advocacy and appropriations measures in support of amFAR's initiatives supporting HIV/AIDs resrearch PEPFAR Reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, State, Dept of (DOS)
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to patent reform Implementation of H.R.5376 Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LILLY USA, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JACOBS ENGINEERING GROUP INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Issues related to healthcare policy and spending
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
CHSPSC, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Issues related to healthcare policy, Covid-19 relief, visas Issues related to telemedicine Provider relief fund Rural extenders Issues related to medical debt
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVEST IN EDUCATION COALITION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Issues related to primary education S. 120 Educational Choice for Children Act H.R.531 Educational Choice for Children Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TYSON FOODS INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
General issues related to food production Issues related to congestion in ports Issues related to IRC Section 45Q Issues related to employer child care tax credits Rural child care pilot program Labor issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSPERITY SERVICES, L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Issues related to Healthcare; Department of Labor regulations; issues related to COVID-19 relief; H.R.5376 Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHEGG, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Issues related to digital learning Workforce Innovation and Opportunity Act Reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS CHILDREN'S HOSPITAL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2023 · first_quarter · Q1
Pediatric health care issues Medicaid coverage and reimbusement Maternal health Pediatric cancer research funding Global vaccine access and funding PACT ACT and CHGME Funding Global pediatric healthcare issues
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office
TYSON FOODS INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · Q4
General issues related to food production, including Covid-19 response and Covid vaccine guidance; Issues related to congestion in ports; Issues related to IRC Section 45Q; Issues related to employer child care tax credits; Rural child care pilot program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MONOGRAM HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · Q4
Issues related to in-home kidney care Medicare advantage
Filing targets: HOUSE OF REPRESENTATIVES
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · Q4
Rural healthcare coverage and reimbursement Student loan repayment Public Health Emergency policies and funding Competition issues Healthcare workforce and staffing issues H.R. 2617, Consolidated Appropriations Act, 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JACOBS ENGINEERING GROUP INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · Q4
Issues related to healthcare policy and spending
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
INVEST IN EDUCATION COALITION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · Q4
Issues related to primary education S.4416 - Educational Choice for Children Act H.R.8137 Educational Choice for Children Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSPERITY SERVICES, L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · Q4
Issues related to Healthcare Department of Labor regulations Issues related to COVID-19 relief H.R.5376 - Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES
TEXAS CHILDREN'S HOSPITAL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · Q4
Pediatric health care issues; Medicaid coverage and reimbursement; Maternal health; Pediatric cancer research funding; Global vaccine access and funding; PACT Act and CHGME Funding; Global pediatric healthcare issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
CHEGG, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · Q4
Issues related to digital learning FY 23 appropriations H.R. 7309 - Workforce Innovation and Opportunity Act of 2022 S 1260 - United States Innovation and Competition Act of 2021 H.R. 4521 - America COMPETES Act of 2022 H.R. 7776, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMFAR THE FOUNDATION FOR AIDS RESEARCH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · Q4
Engage advocacy and appropriations measures in support of amFAR's initiatives supporting HIV/AIDs research
Filing targets: HOUSE OF REPRESENTATIVES, State, Dept of (DOS)
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · 4A
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.5801 - HELP Copays Act H.R.5376 Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · Q4
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.5801 - HELP Copays Act H.R.5376 Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMFAR THE FOUNDATION FOR AIDS RESEARCH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · fourth_quarter · RA
Engage advocacy and appropriations measures in support of amFARs initiatives supporting HIV/AIDS research
MONOGRAM HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · third_quarter · Q3
Issues related to in-home kidney care Medicare advantage
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
JACOBS ENGINEERING GROUP INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · third_quarter · 3A
Issues related to healthcare policy and spending
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
INVEST IN EDUCATION COALITION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · third_quarter · Q3
Issues related to primary education S.4416 - Educational Choice for Children Act H.R.8137 Educational Choice for Children Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JACOBS ENGINEERING GROUP INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · third_quarter · Q3
Issues related to healthcare policy and spending
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA)
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · third_quarter · Q3
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.5801 - HELP Copays Act H.R.5376 Inflation Reduction Act of 2022
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · third_quarter · Q3
Rural healthcare coverage and reimbursement Student loan repayment Public Health Emergency policies and funding Competition issues Healthcare workforce and staffing issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS CHILDREN'S HOSPITAL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · third_quarter · Q3
Pediatric health care issues Medicaid coverage and reimbursement Maternal health Pediatric cancer research funding Global vaccine access and funding PACT ACT and CHGME Funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
TYSON FOODS INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · third_quarter · Q3
General issues related to food production, including Covid-19 response and Covid vaccine guidance Issues related to congestion in ports Issues related to IRC Section 45Q
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHEGG, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · third_quarter · Q3
Issues related to digital learning FY 23 appropriations HR 7309 - Workforce Innovation and Opportunity Act of 2022 S 1260 - United States Innovation and Competition Act of 2021 HR 4521 - America COMPETES Act of 2022 H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSPERITY SERVICES, L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · third_quarter · Q3
Issues related to Healthcare Department of Labor regulations Issues related to COVID-19 relief H.R.5376 - Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES
INSPERITY SERVICES, L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · second_quarter · Q2
Issues related to Healthcare Department of Labor regulations Issues related to COVID-19 relief H.R.5376 - Build Back Better Act
Filing targets: Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL)
CHEGG, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · second_quarter · Q2
Issues related to digital learning FY 23 appropriations H.R. 7309 - Workforce Innovation and Opportunity Act of 2022 S. 1260 - United States Innovation and Competition Act of 2021 H.R. 4521 - America COMPETES Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JACOBS ENGINEERING GROUP INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · second_quarter · Q2
Issues related to healthcare policy and spending
Filing targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT)
TEXAS CHILDREN'S HOSPITAL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · second_quarter · Q2
Pediatric health care issues Global vaccine issues PACT ACT and CHGME Funding
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
TYSON FOODS INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · second_quarter · Q2
General issues related to food production, including Covid-19 response and Covid vaccine guidance Issues related to congestion in ports
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · second_quarter · Q2
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform H.R. 5801 - HELP Copays Act H.R. 5376 - Build Back Better Act
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
TYSON FOODS INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · first_quarter · Q1
General issues related to food production, including Covid-19 response and Covid vaccine guidance Issues related to congestion in ports
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JACOBS ENGINEERING GROUP INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2022 · first_quarter · Q1
Issues related to healthcare policy and spending
Filing targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT)
TYSON FOODS INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2021 · fourth_quarter · 4A
General issues related to food production, including Covid-19 response and Covid vaccine guidance Issues related to congestion in ports
Filing targets: Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, SENATE
TYSON FOODS INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2021 · fourth_quarter · Q4
General issues related to food production, including Covid-19 response and Covid vaccine guidance Issues related to congestion in ports
Filing targets: Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES
TYSON FOODS INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2021 · third_quarter · Q3
General issues related to food production, including Covid-19 response and Covid vaccine guidance Issues related to congestion in ports
Filing targets: Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, SENATE